> Pfizer's vaccine sales grew 10% in the second quarter to $1.4 billion. Release
> Sanofi's vaccines sales slipped during the second quarter due to a supply issue in China; timing of government orders for its polio, pertussis and Hib franchise; and a tough year-over-year comparison for Menactra. Release
> GeoVax teamed with Emory University to develop a therapeutic HPV vaccine. Release
> Sanofi cut a phase 2 tuberculosis vaccine from its pipeline. Endpoints News story